Core Insights - The conference focused on how AI can reshape the value growth curve of Hong Kong-listed companies, emphasizing the importance of innovation and collaboration in driving business growth through technology [1] Group 1: AI Empowering R&D Innovation - AI technology is significantly enhancing R&D efficiency and operational effectiveness in traditional industries, particularly in cancer screening and vaccine development [2][4] - Companies like MiRui are transitioning from traditional statistical models to AI-driven gene diagnosis, which is expected to improve cancer early screening accuracy as data accumulates [1][2] - The integration of AI in R&D processes allows for efficient molecular sequence design and analysis, accelerating the development of innovative vaccines [2][4] Group 2: Optimizing Business Operations - AI is being utilized to enhance operational efficiency in various sectors, including logistics and patient management, leading to improved customer experiences [3][4] - National Pharmaceutical Holdings has implemented AI in its extensive drug distribution network, optimizing inventory management and compliance with healthcare regulations [3] - MiRui's AI platform facilitates training and data interpretation, enhancing communication with clients and healthcare professionals [3] Group 3: Sustainable AI Drive - Companies are recognizing the need to convert AI's potential into sustainable core drivers for their operations, aligning AI technology with strategic development plans [5] - The industry is moving towards a state where AI applications become commonplace and integral to business processes, enhancing competitiveness [5] - Collaboration with leading AI firms is seen as essential for deepening AI integration within industry verticals [5]